Wearable health monitor developer Current Health secured $11.5m in a Legal & General-backed round that took its total funding to nearly $22m.

Immunos Therapeutics has picked up Pfizer Ventures as an investor as it looks to move its lead immuno-oncology drug candidate into clinical testing.

Corporate venturing unit Airbus Ventures has co-led a $16.5m series A round for cost-efficient rocket developer Isar, which is preparing for its first launch in 2021.

Immunos Therapeutics has picked up Pfizer Ventures as an investor as it looks to move its lead immuno-oncology drug candidate into clinical testing.

Ramsay Health Care was among the investors in a $19.8m first funding round for Harrison.ai, which has already formed partnerships with Virtus Health and I-Med.

Unternehmertum Venture Capital Partners has taken part in a $17m series A round for Isar Aerospace, co-founded by three students at TU Munich.

China Union Holdings has invested in the clinical services provider, which was formed by Joinn Laboratories last year and which will put the cash into expanding manufacturing capacity.

Allianz France is among the investors that provided $15.5m for newly launched specialist insurance startup Seyna.

Alexandria Venture Investments has backed a series A round for Jasper Therapeutics, which is developing a conditioning agent for patients awaiting stem cell transplants.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.